Report Search Results	As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 30) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 9-Feb-10 New Constructs, LLC N/A IMMU: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10     View Abstract 9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for IMMU: the economy's impact on IMMU's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15     View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299     View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: IMMUNOMEDICS -- IMMU 1 $4     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ALTUQ , CYTK , IMMU , VITA , TRBN , VICL -- DRUGS 3 $4     View Abstract 1-Feb-10 Zacks Investment Research Inc. N/A IMMUNOMEDICS (IMMU) Zacks Company Snapshot 1 $10     View Abstract 31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: IMMUNOMEDICS INC 5 $25     View Abstract 30-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Immunomedics, Inc. 42 $65     View Abstract 29-Jan-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of IMMUNOMEDICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20     View Abstract Next 20

Brokerage Reports (Showing 1 to 2 of 2) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 25-Jan-10 Brean Murray & Co., Inc. Ling Wang CFA IMMU: ASCO-GI Update 2: Y-90-hPAM4, an Underappreciated Asset, Continues to Showed Great Promise in Pancreatic Cancer 6 $25     View Abstract 22-Jan-10 Brean Murray & Co., Inc. Ling Wang CFA IMMU: ASCO GI Update 1 – PAM4 Shows Promise in Diagnosis – Additional Catalysts on the Horizon 5 $10     View Abstract

Independent Reports (Showing 1 to 10 of 28) Release Date  Contributor Author Title Pages Price More Info 9-Feb-10 New Constructs, LLC N/A IMMU: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract 9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for IMMU: the economy's impact on IMMU's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: IMMUNOMEDICS -- IMMU 1 $4 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ALTUQ , CYTK , IMMU , VITA , TRBN , VICL -- DRUGS 3 $4 View Abstract 1-Feb-10 Zacks Investment Research Inc. N/A IMMUNOMEDICS (IMMU) Zacks Company Snapshot 1 $10 View Abstract 31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: IMMUNOMEDICS INC 5 $25 View Abstract 30-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Immunomedics, Inc. 42 $65 View Abstract 29-Jan-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of IMMUNOMEDICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract Next 18